A Unified 3D Generative Model for Synthesizable Structure-Based Drug Design
Ilia Igashov, Arne Schneuing, Adrian W. Dobbelstein, Irina Morozova, Rebecca M. Neeser, Kara Zielinski, Luciano A. Abriata, Aaron S. Petruzzella, David Robin Pavel Iosub, Olivia Gampp, Artem Y. Lyubimov, Evgenia Elizarova, Isabella Ferrara, Pedro M. F. Sousa, Ana R. Lemos, , Bruno E. Correia
This paper introduces LDDM, a generative model for drug design that produces synthetically accessible compounds validated experimentally for five protein targets.
bioRxiv · Sep 18, 2026 · PreprintBioinformatics